¡GoConqr estrena diseño! Cuéntanos qué te parece.

Fichas

Antibiotics

Anna Hogarth CSP lectures Inglés 29 fichas

Fichas del conjunto (29)

  1. 1Which two classes of antibiotics target the bacterial cell wall?beta-lactams and glycopeptides
  2. 2Which antibiotics target gram +tive bacteria?Penicillins (E,S,S,L)
    Fusidic acid
    Macrolides (Strep only)
    Clindamycin (Strep, some staph)
    Glycopeptides (strep, staph, some e)
    Oxazolidinones (SSE)
    Daptomycin (SSE)
  3. 3Which three classes of antibiotics can be used to treat MRSA? (methicillin-resistant)Oxazolidinones (linezolid), lipopeptide (daptomycin) and glycopeptide (vancomycin)
  4. 4Which antibiotics target gram negative bacteria?Polymixin
    Trimethoprim
    Monobactams
    Temocillin
  5. 5Which antibiotics are broad spectrum?B-lactams:
    Carbapenams
    Amoxicillin/clavulanate
    Piperacillin/tazobactam
    Cephalosporins
    Aminoglycosides
    Chloramphenicol
    Tetracycline
  6. 6For the following AB, describe their use, MOA, spectrum, mechanism of resistance , interactions and SE.X
  7. 7Penicillin1) Meningitis, pneumonia and resp. infections, syphilis
    2) Inhibits transpeptidation of cell wall (-cidal)
    3) Gram positive
    4) Production of B-lactamase and alteration of PBPs: >80% of staphylococci resistant; S. Pneumoniae resistance in USA & S Europe; gonococcal resistance worldwide.
    5) Interactions with allopurinol and methotrexate
    6) Rule out penicillin allergy (IgE), safe in pregnancy and childbirth, Jarisch Herxheimer reaction, coombs positive haemolytic anaemia, interstitial nephritis, serum sickness, hepatitis, drug fever.
  8. 8Amoxicillin1) Used in streptococcal disease, empirically for a sore throat, and listeria bacteria
    2) Inhibits transpeptidation
    3) Gram +tive and -tive
    4) Production B lactamase and alteration PBPs
    5) Interaction with allopurinol
    6) Similar to penicillin, neutropenia, eosinophilia, antibiotic associated diarrhoea (AAD), RASH WITH MONONUCLEOSIS, increased PT and Kounis syndrome
  9. 9Flucloxacillin1) All S. aureus infections except for MRSA
    2) Inhibits transpeptidation
    3) Gram positive (only)
    4) Alteration of PBPs (B-lactamase resistant)
    5) No significant interactions
    6) Cholestasis, hepatitis, rash, leukopenia, anaemia, and thrombocytopenia
  10. 10Co-amoxiclav/Augmentin (amoxicillin + clavulanic acid)1) Polymicrobial infections and B-lactamase producing infections
    2) Transpeptidation inhibitor + B-lactamase inhibitor
    3) Gram +tive, -tive and anaerobes
    4) ESBLs, impermeability, efflux, altered PBPs: MRSA, hospital acquired gram +/- organism (including pseudomonas)
    5) No interactions
    6) See amoxicillin + DRUG INDUCED LIVER INJURY
  11. 11Piptazobactam (piperacillin + tazobactam)1) Polymicrobial infections, b-lactamase producing gram +/- infections and pseudomonas
    2) Transpeptidase inhibitor + B lactamase inhibitor
    3) Gram +/-. anaerobes, pseudomonas
    4) ESBLs, impermeability, efflux, altered PBPs: MRSA, gram - acquired hospital infections including pseudomonas
    5) Methotrexate
    6) Candida, insomnia, hypotension, thrombophlebitis, epistaxis, constipation, hypokalaemia
  12. 12Which class of gram positive bacteria are cephalosporins not active against? Which organism can cephalosporin lead to the proliferation of?Enterococci
    C. dif
  13. 13CefuroximeCephalosporin
    1) Pneumonia, serious intra-abdominal infections and UTIs
    2) Inhibits cell wall synthesis
    3) Gram +/-, not active against pseudomonas spp
    4) ESBLs, impermeability, efflux, altered PBPs: MRSA, hospital acquired gram -tive organisms
    5) No interactions
    6) Rule out pen al (10% cross R), diarrhoea and c. dif
    6)
  14. 14Ceftriaxone1) Meningitis and pneumonia
    2) Inhibits cell wall synthesis
    3) Gram +/-, not active against pseudomonas SPP
    4) ESBLs, impermeability, efflux, altered PBPs: MRSA and hospital acquired gram - infections
    5) RULE OUT PEN AL. Diarrhoea, C. dif, pseudocholelithiasis
    6) No major interaction
  15. 15Ceftazidime1) Serious intra-abdominal infections and UTIs (especially if pseudomonas involved). Cannot be used in CAP (little action against S. pneumoniae)
    2) Inhibits cell wall synthesis
    3) Gram +/- bacteria and PSEUDOMONAS SPP
    4) ESBLs, impermeability, efflux, altered PBPs: MRSA and hospital acquired gram -tive infections
    5) Photosensitive rash, C diff, diarrhoea
    6) No major interaction
  16. 16MeropenemCarbapenem
    1) Polymicrobial infections, ESBL producing gram -tive infections (ICU, haem-onc)
    2) Inhibit cell wall synthesis + B-lactamase inhibitor (including ESBLs)
    3) Gram +/-, pseudomonas and anaerobes
    4) Metallo-B-lactamase, impermeability, efflux, altered PBPs
    5) Rule out pen/ceph al. Rash and seizures
    6) No major interactions
  17. 17Vancomycin/TeicoplaninGlycopeptides
    1) Problem gram + infections (e.g. MRSA)
    2) Inhibits cell wall synthesis
    3) Gram + C. diff
    4) Alteration of binding site: vancomycin resistant enterococcus
    5) Vancomycin is nephrotoxic (red man syndrome)
    6) No significant interactions
  18. 18What are the protein synthesis inhibitors?Aminoglycosides, tetracyclines, chloramphenicol, macrolides, clindamycin, fusidic acid
  19. 19Gentamicin and amikacin Bactericidal (only one of the protein synthesis inhibitors)Aminoglycosides
    1) Adjunct to systemic sepsis including pseudomonas. Bacterial synergy with B lactam for IE and group B enterococcal sepsis. MRSA and others.
    2) Irreversible inhib. of protein synthesis (30S) - O2 dependent (i.e. aerobes only)
    3) Gram +/- and not pseudomonas spp
    4) Impermeability, efflux - acquired resistance in gram -tive
    5) Nephrotoxicity and ototoxicity
    6) Increase nephrotoxicity with vancomycin, colistin and ambisome
  20. 20Erythromycin, clarithromycin, azithromycinMacrolides
    1) Used in atypical agents; penicillin allergy, H. pylori infections, STIs etc.
    2) Bacteriostatic inhibition of protein synthesis (50S)
    3) Gram + and H influenzae
    4) Mutation of binding site - staphylococcus and streptococcus
    5) Inhibits P450 and causes QT prolongation
    6) No major interactions
  21. 21Quinolones (ciprofloxacin, moxifloxacin, levofloxacin) Rifampicin MetronidazoleInhibit nucleic acid metabolism. Metronidazole is not active against most aerobes. Quinolones are the only oral anti-pseudomonas agent.
    Poor selective toxicity
  22. 22Cipro/levo/moxifloxacinQuinolones
    1) Serious intra-abdominal and urinary tract infections, especially if pseudomonas are involved. Not used for pneumonia. Can be used in TB.
    2) Inhibits DNA gyrase
    3) Gram -/+, can't be used in pseudomonas
    4) Impermeability and efflux: high rates of resistance
    5) NOT LICENSED IN PREGNANCY. AAD, lowers seizure threshold, tendon rupture.
    6) No major interaction
  23. 23Sulphonamide and trimethoprimAntifolates
    S - inhibits dihydropteroate synthase
    T - inhibits dihydrofolate reductase (50,000 X more active than bacterial enzyme)
    We lack dihydropteroate synthase but do have dihydrofolate reductase
  24. 24Amphotericin Colistin DaptomycinMembrane disorgansing agents - poor selective toxicity
    Amphotericin - antifungal agent
    Colistin - polymixin
    Daptomycin (lipopeptide which can be used to treat MRSA)
  25. 25Which antibiotics show true synergy?B-lactams and aminoglycoside in endocarditis and group B enterococcus
  26. 26Which antibiotic classes show antagonism?Tetracycline or chloramphenicol with B-lactam or aminoglycoside.
    Two beta-lactams together
  27. 27Which antibiotics are used for ESBLs?Meropenem
    Tazobactam, clavulanic acid
    Non-beta lactamases
    Colistin if all others have failed
  28. 28Which antibiotics are used in penicillin allergies?Tetracyclines, aminoglycosides, quinolones, glycopeptides
  29. 29Which antibiotics are used to treat pseudomonas? Which is the only oral option?Ceftazidime (cephalosporin), quinolones, carbapenems, gentamicin
    Quinolones

Información

Descripción
CSP lectures Fichas sobre Antibiotics, creado por Anna Hogarth el 30/10/2019.
Creado por
Anna Hogarth
Visitas
1
Valoración

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?